Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.
S L Walsh, E C Strain, M E Abreu...
https://pubmed.ncbi.nlm.nih.gov/11594439Completed
Age: 21Years - 50Years
All Genders
Healthy Volunteers
ID00000323
Therapeutic Potential of Kappa-Opioids Against Cocaine
Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12
10
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.
CONDITIONS
Official Title
Therapeutic Potential of Kappa-Opioids Against Cocaine - 1
Who Can Participate
Age: 21Years - 50Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
opiate experienced, healthy
You will not qualify if you...
physical dependence on opioids, barbiturates or alcohol
Trial Site Locations
Total: 1 location
1
Johns Hopkins University (BPRU) Bayview Campus
Baltimore, Maryland, United States, 21224 6823
Status Unknown
Loading map...
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here